At the heart of the complaint are comments made by Martin Holst Lange, formerly the company's head of development and now its chief scientific officer, who is accused of concealing that the dosing regimen in REDEFINE-1 was flexible, allowing patients to modify their dose of CagriSema throughout the trial to limit side effects, which meant that just 57% of them received the highest dose of the drug
Loss of lipid deposition caused by kin-19 RNAi was not observed in the nhr-49(nr2041) mutant animals as monitored by DHS-3::GFP fluorescence (Fig
Several factors likely caused these different results
Injury and Trauma : Physical wounds like burns, cuts, or abrasions can compromise the skin's barrier of defence and cause infections or scarring
CrossRef Sarcopenia as a risk factor for nonalcoholic fatty liver disease and liver fibrosis: an updated systematic review and meta-analysis Xinrong Zuo, Doudou Chen, Yi Kang, Xinyi Hu, Yarong Zhang, Kuo Tang, Junhua Shi, Tao Li, Wangning Shangguan Frontiers in Nutrition.2026;[Epub] CrossRef Sarcopenia in patients with non-alcoholic fatty liver disease: pathogenesis, diagnosis and treatment (expert opinion) L
Food Sci Nutr